insulin detemir vs pramlintide
Side-by-side comparison of insulin detemir and pramlintide. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
moderate Known Drug Interaction
Table 6: Clinically Significant Drug Interactions with LEVEMIR Drugs That May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogs (e.g., octreotide), and sulfonamide antibiotics, GLP-1 receptor agonists, DPP-4 inhibitors, SGLT-2 inhibitors.
Recommendation: Your doctor may need to lower your insulin dose, and you should check your blood sugar more often.
Levemir
Symlin
Levemir is a long-acting insulin that helps control blood sugar levels in people with diabetes. It works slowly over about 24 hours to keep your blood sugar stable.
Symlin is a drug that helps control blood sugar in people with type 1 or type 2 diabetes who also use insulin. It works with insulin to lower blood sugar levels after meals.
Levemir is used to improve blood sugar control in adults and children with diabetes. It helps manage high blood sugar levels. However, it is not used to treat diabetic ketoacidosis, a serious condition with very high blood sugar and ketones.
Symlin is used to help manage blood sugar levels in adults with type 1 or type 2 diabetes. You should already be using insulin at mealtimes. This medicine is for people whose blood sugar is not well-controlled, even with the best insulin treatment.
Levemir is a long-acting form of insulin. It works by helping your body use sugar from the blood for energy. This lowers your blood sugar levels and keeps them more stable over time.
Symlin is similar to a natural hormone in your body. It slows down how quickly food leaves your stomach. It also helps to prevent your liver from releasing too much sugar after you eat, and reduces your appetite.
- • Upper respiratory infection
- • Headache
- • Sore throat
- • Flu-like illness
- • Abdominal pain
- • Nausea
- • Vomiting
- • Loss of appetite
- • Headache
- • Fatigue
- High blood sugar 6,220
- Feeling sick to your stomach 1,971
- Low blood sugar 1,568
- Feeling tired 1,534
- Loose stools 1,399
- High blood sugar 15
- Sudden kidney damage 11
- Long-term kidney disease 11
- Feeling sick to your stomach 9
- Shortness of breath 8
Never share your Levemir FlexPen, needle, or insulin syringe with anyone else, even if you change the needle. Sharing these items can spread blood-borne diseases. Changes in your insulin regimen can cause high or low blood sugar. Always check the insulin label before injecting to avoid medication errors. Low potassium can occur, monitor potassium levels. Heart failure can occur when taking Levemir with thiazolidinediones (TZDs).
Symlin can cause very low blood sugar, especially if you have type 1 diabetes. This can happen within 3 hours after a Symlin shot. To avoid this, follow your doctor's instructions carefully and check your blood sugar often. Make sure you know the signs of low blood sugar.
Tell your doctor if you are pregnant or plan to become pregnant. Good control of diabetes is important during pregnancy for both you and your baby. Levemir can be used during pregnancy.
It is not known if Symlin will harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if Symlin passes into breast milk, so discuss breastfeeding with your doctor.
Also Compare, Nearby Drugs
Compare insulin detemir with
How to Read This insulin detemir vs pramlintide Comparison
insulin detemir is classified in the Long-Acting Insulin drug class, while pramlintide sits within the Amylin Analog class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, insulin detemir has 12,692 submissions while pramlintide has 54. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known moderate interaction flagged in FDA labeling, attributed to both drugs lower blood sugar, so taking them together increases the chance of your blood sugar dropping to a dangerous level.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between insulin detemir and pramlintide - always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.